FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072008 [Registered on: 06/08/2024] Trial Registered Prospectively
Last Modified On: 03/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Accuracy of Sleep Apnea Questionnaires in Adults: Hospital Study 
Scientific Title of Study   Diagnosis accuracy of screening questionnaires for obstructive sleep apnea in adults -a hospital based cross-sectional study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Nakwa fathima sadaf 
Designation  Student 
Affiliation  Rajiv gandhi university of health sciences 
Address  Department of Pharmacology, Karavali College of Pharmacy, Vamanjoor, Mangalore, Karnataka-575028 Dakshina Kannada KARNATAKA 575028 India
Department of Pharmacology, Karavali College of Pharmacy, Vamanjoor, Mangalore, Karnataka-575028 Dakshina Kannada
Dakshina Kannada
KARNATAKA
575028
India 
Phone  7337877844  
Fax    
Email  zaraasmaaras0@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Thanveer ahammed chonari 
Designation  Assistant Professor 
Affiliation  Karavali college of pharmacy 
Address  Department of Pharmacology, Karavali College of Pharmacy, Vamanjoor, Mangalore, Karnataka-575028 Dakshina Kannada KARNATAKA 575028 India

Dakshina Kannada
KARNATAKA
575028
India 
Phone  8921269228  
Fax    
Email  thanveerahammed24@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Thanveer ahammed chonari 
Designation  Assistant Professor 
Affiliation  Karavali college of pharmacy 
Address  Department of Pharmacology, Karavali College of Pharmacy, Vamanjoor, Mangalore, Karnataka-575028 Dakshina Kannada KARNATAKA 575028 India


KARNATAKA
575028
India 
Phone  8921269228  
Fax    
Email  thanveerahammed24@gmail.com  
 
Source of Monetary or Material Support  
Father Muller Medical College Hospital, Mangalore, Karnataka 
 
Primary Sponsor  
Name  Nakwa fathima sadaf 
Address  Department of Pharmacology, Karavali College of Pharmacy, Vamanjoor, Mangalore, Karnataka-575028 Dakshina Kannada KARNATAKA 575028 India 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Nakwa fathima sadaf  father muller medical college  father muller road, father muller hospital, department of pulmonology, 1st floor,kankanady-575002
Dakshina Kannada
KARNATAKA 
7337877844

zaraasmaaras0@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Father Muller Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G473||Sleep apnea,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  nil  nil 
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Patients who are diagnosed with obstructive sleep apnea.
Patient who presents with snoring
 
 
ExclusionCriteria 
Details  Patients who are diagnosed with psychiatric illness.
Pregnant and lactating women.
Patients who are unresponsive, unconscious, and comatose.
Patients diagnosed with central sleep apnea
Patient who doesn’t give h/o of snoring
Patients who refuse to give consent.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
the study result will explore the diagnostic accuracy of screening questionnaires, such as the Epworth Sleepiness Scale and STOP-BANG questionnaire, in assessing obstructive sleep apnea (OSA) among adults. These tools are widely used in clinical settings to identify individuals at risk for OSA based on symptoms and other criteria.  0 15 30days 
 
Secondary Outcome  
Outcome  TimePoints 
In this study, we aim to determine the demographic characteristics of patients diagnosed with obstructive sleep apnea through sleep studies, assess the positive predictive value of the Epworth Sleepiness Scale (ESS) and STOP-BANG questionnaires, and classify cases of obstructive sleep apnea into mild, moderate, and severe categories using established criteria such as the Apnea-Hypopnea Index.  0 15 30days 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   14/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Obstructive sleep apnea (OSA) is characterized by recurrent upper airway obstruction during sleep, leading to arousals and oxygen desaturation. Common symptoms include snoring during sleep and excessive daytime sleepiness or fatigue. Polysomnography (PSG) is the gold standard for diagnosis but is costly and time-consuming. Screening tools like the Epworth Sleepiness Scale (ESS) and STOP-Bang questionnaire (SBQ) offer easier, more accessible ways to assess OSA risk. PSG measures various parameters including the Apnea-Hypopnea Index (AHI) to classify OSA severity (normal, mild, moderate, severe). OSA is associated with conditions like obesity and metabolic syndrome, highlighting the need for effective screening and management strategies.

 
Close